Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2022   7,976,980    
Beginning balance at Dec. 31, 2022 $ 121,333 $ 1 $ 300,645 $ (179,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cash paid for fractional shares from the Reverse Stock Split (in shares)   (552)    
Cash paid for fractional shares from the Reverse Stock Split (3)   (3)  
Vesting of restricted stock units, net (in shares)   334,809    
Stock-based compensation 17,958   17,958  
Net loss $ (124,015)     (124,015)
Ending balance (in shares) at Dec. 31, 2023 8,311,237 8,311,237    
Ending balance at Dec. 31, 2023 $ 15,273 $ 1 318,600 (303,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   344,885    
Stock-based compensation 4,129   4,129  
Net loss $ (119,902)     (119,902)
Ending balance (in shares) at Dec. 31, 2024 8,656,122 8,656,122    
Ending balance at Dec. 31, 2024 $ (100,500) $ 1 $ 322,729 $ (423,230)